Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ACT Genomics

ACT Genomics

Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment and monitoring. The company's cancer molecular information services implement next-generation sequencing and multiplex molecular testing, coupled with bioinformatics tool, curated proprietary databases and data visualization technologies, enabling cancer patients to address the key challenges in cancer treatments.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Medical Records Systems
Primary Office
  • 1F., Number 280
  • Xinhu 2nd Road
  • Taipei City, Neihu District 114
  • Taiwan

+886 02 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ACT Genomics’s full profile, request a free trial.

ACT Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 05-Jul-2019 $5M 0000 Completed Generating Revenue
3. Early Stage VC 26-Sep-2018 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 01-May-2016 $12.5M $20.5M Completed Startup
1. Early Stage VC (Series A) 13-Feb-2015 $8M $8M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ACT Genomics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Theranosis Life Sciences Accelerator/Incubator Backed Hyderabad, India 000.00 0000000000 000.00
000000 (0000 00000 Venture Capital-Backed Bangalore, India 000 000.00 0000000000 0 000.00
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 00000 000000&0 00000
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
0000 00 0000 Accelerator/Incubator Backed Houston, TX 000000000000
To view this company’s complete list of competitors, request access »

ACT Genomics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Mar-2017 00000 0000000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

ACT Genomics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 01-Mar-2017 00000 0000000 Completed
  • 2 buyers
To view this company’s complete exits history, request access »

ACT Genomics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
CLSA Capital Partners PE/Buyout Minority 000 0000 000000 0
CDIB Capital International PE/Buyout Minority 000 0000 000000 0
Hotung Investment Holdings Venture Capital Minority 000 0000 000000 0
Eminent Venture Capital Venture Capital Minority 000 0000 000000 0
Hua Nan Venture Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

ACT Genomics Executive Team (5)

Name Title Board
PJ Hsueh Chief Operating Officer
Hua-Chien Chen Ph.D Co-Founder and Chief Executive Officer
Victor Chan Chief Financial Officer
Shu-Jen Chen Ph.D Co-Founder & Chief Scientific Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »